MedPath

Patient Education in Pregnant Women With Asthma

Completed
Conditions
Asthma
Registration Number
NCT05459012
Lead Sponsor
CHU de Reims
Brief Summary

Pregnancy may impact treatment adherence in women with asthma. This is a major risk factor for asthma exacerbation, which may have an important impact for both women and the babies. This study aims to evaluate the impact of a targeted patient education action tailored for pregnant women with asthma.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
5
Inclusion Criteria
  • Adult pregnant women with asthma
Exclusion Criteria
  • women not able to speak and/or read French language
  • women protected by the law

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change from Asthma quality of life between two periods : before intervention and 3 month after the interventionbefore and 3 month after the intervention

The physician gives Asthma quality of life questionnaire (AQLQ) before intervention and 3 month after the intervention

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Chu Reims

🇫🇷

Reims, France

Chu Reims
🇫🇷Reims, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.